Tag: News

Register Now! In French 🇫🇷 Webinar Neuro-Oncology Imaging: New Perfusion Markers to Optimize Diagnosis and Follow-up We invite you to an exclusive session hosted by Professor Nadya Pyatigorskaya, a renowned…

Cercare Medical Joins SFNR 2025! Cercare Medical is excited to announce our participation in SFNR 2025, hosted by the French Society of Neurology, from March 12 - 14, 2025, at…

PRESS RELEASE Cercare Medical Secures €7.4 Million in New Funding Round to Accelerate Growth in Key Markets Expansion Targets Leading Oncology and Stroke Clinics in the United States and Europe.…

PRESS RELEASE Cercare Medical Secures FDA Clearance for CT Perfusion Imaging Software Milestone Achievement Expands Availability of Advanced Perfusion Imaging in Stroke Care. AARHUS, DENMARK, 12 Dec 2024: Cercare Medical is proud…

PRESS RELEASE Cercare Medical Launches Version 16 of Neurosuite: Showcasing Innovation at RSNA 2024  CMN Version 16 delivers innovative capabilities for clinical and research use. AARHUS, DENMARK, 2 Dec 2024: Cercare…

PRESS RELEASE Exclusive Evening Event at RSNA 2024 Features Dr. Alexandre Bani-Sadr  Explore Innovations in Metabolic Perfusion Imaging and Discover the Latest Breakthroughs in Stroke and Neuro-Oncology Care. CHICAGO, IL,…

PRESS RELEASE Groundbreaking Study Highlights Cercare Medical’s Role in Stroke Treatment Innovations Lyon Team's Study, Led by Dr. Bani-Sadr, Demonstrates How Advanced Biomarkers are Transforming Stroke Care. AARHUS, DENMARK, 27…

Product Overview: Discover the Right Application for You

Stroke ManagementM1 occlusionOEF increase Oncology Glioblastoma tumor recurrenceOEF increase Have you ever heard about Oxygen Extraction Fraction (OEF)? It’s an important biomarker in Cercare Medical Neurosuite software that ensures high-quality…

Cercare Medical to Showcase Advanced MRI Solutions at SIIM 2024 Join Randy Rhomer & Shannon Brickman at SIIM 2024 Event Details:Dates: June 27-29, 2024Location: Booth 212, SIIM Annual Meeting Special…